Congenital (cTTP) and immune-mediated (iTTP) thrombotic thrombocytopenic purpura are
serious and rare clotting disorders resulting from a deficiency in the ADAMTS13 enzyme. A …

Acquired thrombotic thrombocytopenic purpura (TTP) is a rare thrombotic microangiopathy
caused by the immune-mediated severe deficiency of ADAMTS13. We hereby report the …

Introduction Thrombotic thrombocytopenic purpura (TTP) is associated with high mortality if
not managed timeously with therapeutic plasma exchange (TPE). TTP secondary to human …

Introduction Acquired thrombotic thrombocytopenic purpura (aTTP) is a rare life-threatening
thrombotic microangiopathy (TMA) affecting more frequently women of 30–50 years of age …

Background Immune-mediated thrombotic thrombocytopenic purpura (iTTP) is a
microangiopathy often characterized by acute neurological involvement including ischemic …

Background Thrombotic thrombocytopenic purpura (TTP) is a hematologic disease that can
be fatal if not treated early. We aimed to describe the clinical characteristics of Mexican …

Background Thrombotic thrombocytopenic purpura (TTP) is a rare, life-threatening
thrombotic microangiopathy (TMA) requiring urgent treatment. Standardization of its …

Thrombotic thrombocytopenic purpura (TTP) is clinically caused by severely deficient activity
of the ADAMTS-13 protease. The classical pentad of TTP, microangiopathic hemolytic …

Trombotik trombositopenik purpura (TTP) klinik olarak ADAMTS-13 proteazının eksik
aktivitesinden kaynaklanır. TTP'nin klasik pentadı mikroanjiyopatik hemolitik anemi (MAHA) …

This is a retrospective study of the clinical and laboratory features, management, and
outcome of 41 adults diagnosed with thrombotic thrombocytopenic purpura (TTP) at the …